 multipl sclerosi prolong administr studi efficaci singl oral dose motor visual sign multipl sclerosi MS patient mean hour efficaci multipl daili dose sever day mg temperature-sensit MS patient daili dose interv day double-blind studi nine patient placebo thirteen patient import motor visual improv placebo group averag peak improv score placebo seventi percent daili improv hour improv consecut dose mean hour averag treatment-observ period hour placebo averag treatment-observ period seriou side effect promis drug symptomat treatment MS